Amarin Corporation plc (NASDAQ: AMRN) (Amarin), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today announced new data from a post hoc analysis of the ...
Weight loss company Noom is offering an at-home biomarker testing kit for its U.S. members, expanding its platform into ...
LDL cholesterol is an important marker, but others such as ApoB, hs-CRP, and insulin resistance should not be ignored, shares ...
When directly comparing the protein content, peanuts have a slight edge over almonds. However, neither peanuts nor almonds ...
Researchers at UT Southwestern Medical Center have identified a protein that acts as a key regulator of how the liver releases cholesterol carrying ...
Obesity alters the biological mechanisms through which early noninvasive breast cancer becomes invasive — that is, it spreads ...
Moderate weight loss through diet does not alleviate the symptoms of atrial fibrillation in the elderly and does not affect ...
Growing body of clinical and real-world evidence supports the role of Rezdiffra® (resmetirom) as the foundational therapy for patients with MASH ...
LIB Therapeutics Inc. (LIB), a privately-held, biopharmaceutical company with a recently approved novel, monthly, small-dose, third-gene ...
Cardiology attracted me because it was a logical specialty. At that time, it was relatively limited, and we often thought in ...
YouTube on MSN
Cholesterol debates in an era of medical mistrust
My goal in this letter is to begin to reconcile one of the most divisive and important debates in healthcare and nutrition today: the role of cholesterol in heart disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results